Catalysts for Seagen Inc
4 tracked
Nov 12, 2025
approval
TIVDAK (TISOTUMAB VEDOTIN-TFTV) — FDA approval
tisotumab vedotin
→
Apr 29, 2024
approval
TIVDAK (TISOTUMAB VEDOTIN-TFTV) — FDA approval
tisotumab vedotin
→
Jul 26, 2023
approval
TIVDAK (TISOTUMAB VEDOTIN-TFTV) — FDA approval
tisotumab vedotin
→
Sep 20, 2021
approval
TIVDAK (TISOTUMAB VEDOTIN-TFTV) — FDA approval
tisotumab vedotin
→